Cortical slices following malignant glioma implantation demonstrate increased glutamate release from the tumor mass, mediated by the cystine/glutamate antiporter xc− [17, 18, 30], whose expression is anticorrelated to this of p53 [19]. The gene discussed is TP53; the disease is malignant glioma.